{"entity":{"id":"nct06513455","kind":"trial","name":"Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer","aka":[],"tldr":"A phase 1/2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Harbin Medical University, not yet recruiting.","summary":"Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer is a phase 1/2, randomised interventional study registered as NCT06513455 by Harbin Medical University, with a registry enrolment figure of 132 participants, started 2024-09-01 and due to reach its primary completion in 2027-06-30. Interventions recorded: Irinotecan liposome（40mg/m2）; Nab-paclitaxel; Gemcitabine; Irinotecan Liposome（60mg/m2）. Conditions listed: Pancreatic Cancer. Primary outcome: MTD /DLT (phase I); ORR(phase II). Pancreatic eligibility wording from the registry: \"Patients with pancreatic cancer diagnosed by histology or cytology;\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06513455","url":"https://clinicaltrials.gov/study/NCT06513455"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["locally-advanced-pdac","metastatic-pdac"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["nab-paclitaxel","gemcitabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06513455","phase":"1/2","setting":"Irinotecan Liposome Combined With Albumin Paclitaxel and Gemcitabine as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer","sponsor":"Harbin Medical University","enrolled":132,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06513455/","neighbours":{"cancer":[{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"gemcitabine","kind":"drug","name":"Gemcitabine","route":"/drugs/gemcitabine/"},{"id":"nab-paclitaxel","kind":"drug","name":"Nab-paclitaxel","route":"/drugs/nab-paclitaxel/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}